Friday, August 19, 2022 | Back issues
Courthouse News Service Courthouse News Service

Patent & Trademark

Pfizer and Dr. Robert Jarvik insist their use and promotion of Lipitor and Caduet do not violate Dr. Mathew Gelfand's patent on "use of thrombolytic reagents for prevention of vascular disease," which patent they say is invalid and unenforceable, in Manhattan Federal Court.

Breaking the Chain Foundation claims Capitol Educational Support violates its "Breaking the Chain" trademark, in DC Federal Court. Both groups say they are trying to eradicate intergenerational incarceration in the Capital Area.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...